REGN

Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
$794.19
-13.52 (-1.67%)
Mkt Cap: 81.82B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield5.1%
Dividend YieldN/A
Market Cap81.82B
Volume487.7K
Recent News
Regeneron Pharmaceuticals, Inc. (REGN) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 14, 2026 Lead Plaintiff Deadline
gurufocus.com · 2026-08-28
Regeneron Pharmaceuticals, Inc. (REGN) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 14, 2026 Lead Plaintiff Deadline
prnewswire.com · 2026-08-28
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
prnewswire.com · 2026-08-27
REGN SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
newsfilecorp.com · 2026-08-27
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com · 2026-08-27
REGN DEADLINE: SueWallSt Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Securities Class Action Deadline
prnewswire.com · 2026-08-27

Unlock the Full Deep Scan

9 AI agents analyze REGN across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →